A phase II trial of sorafenib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial

被引：0
|
作者：
Williamson, S. K.
Moon, J.
Huang, C. H.
Guaglianone, P.
Wolf, G. T.
Urba, S. G.
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[2] Southwest Oncol Grp, Ctr Stat, Seattle, WA USA
[3] Canc Care Specialists Cent Illinois, Decatur, IL USA
[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6044
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of BAY 43-9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). A Southwest Oncology Group (SWOG) trial
    Williamson, S.
    Moon, J.
    Huang, C.
    Wolf, G.
    Urba, S.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 286 - 286
  • [2] A phase II trial of BAY 43-9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial.
    Williamson, S. K.
    Moon, J.
    Huang, C. H.
    Guaglianone, P.
    Wolf, G. T.
    Urba, S. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 292S - 292S
  • [3] PHASE-II TRIAL OF PIROXANTRONE IN PATIENTS WITH RECURRENT AND METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A SOUTHWEST-ONCOLOGY-GROUP TRIAL
    TAYLOR, SA
    BENEDETTI, J
    SCHULLER, D
    RICHMAN, SP
    BROUN, GO
    HANTEL, A
    [J]. INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 227 - 229
  • [4] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma
    Elser, Christine
    Siu, Lillian L.
    Winquist, Eric
    Agulnik, Mark
    Pond, Gregory R.
    Chin, Soo F.
    Francis, Peggy
    Cheiken, Robin
    Elting, James
    McNabola, Angela
    Wilkie, Dean
    Petrenciuc, Oana
    Chen, Eric X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773
  • [5] Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study
    Wolfram E. Samlowski
    Holly Gundacker
    J. Philip Kuebler
    Jeffrey K. Giguere
    Glenn M. Mills
    David E. Schuller
    John F. Ensley
    [J]. Investigational New Drugs, 2001, 19 : 311 - 315
  • [6] Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study
    Samlowski, WE
    Gundacker, H
    Kuebler, JP
    Giguere, JK
    Mills, GM
    Schuller, DE
    Ensley, JF
    [J]. INVESTIGATIONAL NEW DRUGS, 2001, 19 (04) : 311 - 315
  • [7] Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck - A phase II Southwest Oncology Group study
    Smith, RE
    Lew, D
    Rodriguez, GI
    Taylor, SA
    Schuller, D
    Ensley, JF
    [J]. INVESTIGATIONAL NEW DRUGS, 1996, 14 (04) : 403 - 407
  • [8] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
  • [9] A phase II trial of biweekly gemcitabine and paclitaxel (GEMTAX) combination in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group study
    Bickel, K. E.
    Worden, F. P.
    Moon, J.
    Kucuk, O.
    Wheeler, R. H.
    Clark, J.
    Wolf, G. T.
    Urba, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329
    Malhotra, Binu
    Moon, James
    Kucuk, Omar
    Clark, Joseph I.
    Urba, Susan G.
    Wolf, Gregory T.
    Worden, Francis P.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (12): : 1712 - 1717
12345